Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)

ABSTRACT: ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and archival samples to be used for validation and correlative studies on markers discovered by cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving heterogeneity of colorectal cancer (CRC): from mechanism to therapies" (an ongoing multi-institutional research program).

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2394032 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Single-cell proteomics captures the Proteome Heterogeneity in Human iPSC-Derived Cardiomyocytes and Adult Cardiomyocytes

Project description:Human induced pluripotent stem cell (IPSC)-derived cardiomyocytes (iCMs) have become important tools to model cardiovascular diseases and drug toxicology. Despite suggested transcriptomic heterogeneity in both iPSC and iCMs, the cellular proteome heterogeneity is poorly understood. Using cutting-edge single cell proteomics, we quantify the maturation from IPSC to iCMs and observed two distinct populations of iCMs with different metabolism, which recapitulates the single adult cardiomyocyte proteome populations albeit less mature.

2024-03-29 | MSV000094438 | MassIVE

Patient-derived airway organoids from BAL fluid model injury and therapy responses in neonatal bronchopulmonary dysplasia [BAL Organoids Single Cell]

Project description:Lung tissue from fetal and neonatal lung samples is tough to obtain, and capturing cells from a living patient with evolving or established disease is very challenging. We hypothesized that airway organoids derived from BAL samples from intubated preterm neonates with established BPD will recapitulate the epithelial heterogeneity seen in human airways and can be used for studying injury and therapy responses in vitro. BPD patient BAL-derived airway organoids exhibited cellular heterogeneity consistent with that observed in the human airway. BAL sample-derived airway organoids from patients with established BPD contain basal cell progenitors and a spectrum of differentiated epithelial subtypes, including secretory, ciliated, PNECs, and hillock cells. Hyperoxia exposure and treatment with dexamethasone caused significant cellular transcriptional changes and highlighted biological pathways, both known and novel. Sex as a biological variable modulates the response of the BAL-derived airway organoid to hyperoxia exposure and treatment with dexamethasone. We also validated our findings in an independent dataset from human BPD lung samples. BAL-derived human lung organoids represent a cutting-edge model that bridges a critical gap in BPD research. They combine the advantages of being patient-specific and capturing developmental lung biology, with the experimental flexibility of an in vitro system.

2026-07-31 | GSE304210 | GEO

Patient-derived airway organoids from BAL fluid model injury and therapy responses in neonatal bronchopulmonary dysplasia [Oxygen Sex Comparisons]

2026-07-31 | GSE304208 | GEO

Patient-derived airway organoids from BAL fluid model injury and therapy responses in neonatal bronchopulmonary dysplasia [NGFR]

2026-07-31 | GSE304206 | GEO

Patient-derived airway organoids from BAL fluid model injury and therapy responses in neonatal bronchopulmonary dysplasia [Oxygen vs Room Air]

2026-07-31 | GSE304203 | GEO

Patient-derived airway organoids from BAL fluid model injury and therapy responses in neonatal bronchopulmonary dysplasia [Dexamethasone]

2026-07-31 | GSE304202 | GEO

Investigating ischemia and reperfusion-induced organ damage in severe cardiac arrest: A comprehensive proteomics perspective

Project description:Cardiac arrest (CA) is a life-threatening condition with complex pathophysiology and limited treatment options. To gain deeper insights into the pathological state of vital organs, we utilize cutting-edge proteomics analysis in rodents to evaluate the proteome dynamics of the brain, heart, kidney, and liver at the organ, organelle, and molecular levels following CA and resuscitation.

2023-06-28 | MSV000092303 | MassIVE

Long non-coding RNA landscape of patients biopsies from advanced Triple Negative Breast Cancer

Project description:The response to specific treatments relies on precise biomarkers, thereby avoiding undesirable toxicities and diminishing the cost. Due to the lack of treatment options in triple-negative breast cancer, it is crucial to search biomarkers with reasonable specificity and sensibility to recognize clusters of patients who could benefit from the cutting-edge oncologist treatments available nowadays. Microarrays were used to detail the global gene expression program to stratified TNBC patients according to TNBCtype software developed by Vanderbilt University and then identified lncRNAs expressed differentially through the TNBC subtypes.

2021-06-04 | GSE176128 | GEO

Proteomic Profiling of Human Plaque Compartments: Fibrous Cap, Core, and Media

Project description:The proteome of human plaque, fibrous cap, core, and media was unveiled using fully automated sample preparation platform AccelerOme and cutting-edge DIA mass spectrometry.

2025-02-24 | MSV000097207 | MassIVE